A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase

Influenza A virus (IAV) causes seasonal epidemics and occasional but devastating pandemics, which are major public health concerns. Because the effectiveness of seasonal vaccines is highly variable and the currently available drugs are limited in their efficacy because of the emergence of drug resis...

Full description

Bibliographic Details
Main Authors: Ping Li, Qinghua Cui, Lin Wang, Xiujuan Zhao, Yingying Zhang, Balaji Manicassamy, Yong Yang, Lijun Rong, Ruikun Du
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/10/6/325
_version_ 1818911581967220736
author Ping Li
Qinghua Cui
Lin Wang
Xiujuan Zhao
Yingying Zhang
Balaji Manicassamy
Yong Yang
Lijun Rong
Ruikun Du
author_facet Ping Li
Qinghua Cui
Lin Wang
Xiujuan Zhao
Yingying Zhang
Balaji Manicassamy
Yong Yang
Lijun Rong
Ruikun Du
author_sort Ping Li
collection DOAJ
description Influenza A virus (IAV) causes seasonal epidemics and occasional but devastating pandemics, which are major public health concerns. Because the effectiveness of seasonal vaccines is highly variable and the currently available drugs are limited in their efficacy because of the emergence of drug resistance, there is an urgent need to develop novel antivirals. In this study, we characterized a recombinant IAV-carrying Gaussia luciferase (Gluc) gene and determined its potential as a tool for evaluating therapeutics. We demonstrated that this recombinant IAV is replication-competent in tissue culture and pathogenic in mice, although it is slightly attenuated compared to the parental virus. Luciferase expression correlated well with virus propagation both in vitro and in vivo, providing a simple measure for viral replication in tissue culture and in mouse lungs. To demonstrate the utility of this virus, ribavirin and oseltamivir phosphate were used to treat the IAV-infected cells and mice, and we observed the dose-dependent inhibition of viral replication by a luciferase assay. Moreover, the decreased luciferase expression in the infected lungs could predict the protective efficacy of antiviral interventions as early as day 2 post virus challenge. In summary, this study provides a new and quantitative approach to evaluate antivirals against IAV.
first_indexed 2024-12-19T23:00:59Z
format Article
id doaj.art-6bb8ba3fd38a4637882a696380b14f59
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-12-19T23:00:59Z
publishDate 2018-06-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-6bb8ba3fd38a4637882a696380b14f592022-12-21T20:02:31ZengMDPI AGViruses1999-49152018-06-0110632510.3390/v10060325v10060325A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia LuciferasePing Li0Qinghua Cui1Lin Wang2Xiujuan Zhao3Yingying Zhang4Balaji Manicassamy5Yong Yang6Lijun Rong7Ruikun Du8College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, ChinaCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, ChinaCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, ChinaCollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, ChinaShandong Provincial Collaborative Innovation Center for Antiviral Traditional Chinese Medicine, Jinan 250355, ChinaDepartment of Microbiology, University of Chicago, Chicago, IL 60637, USAShandong Provincial Collaborative Innovation Center for Antiviral Traditional Chinese Medicine, Jinan 250355, ChinaDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USACollege of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, ChinaInfluenza A virus (IAV) causes seasonal epidemics and occasional but devastating pandemics, which are major public health concerns. Because the effectiveness of seasonal vaccines is highly variable and the currently available drugs are limited in their efficacy because of the emergence of drug resistance, there is an urgent need to develop novel antivirals. In this study, we characterized a recombinant IAV-carrying Gaussia luciferase (Gluc) gene and determined its potential as a tool for evaluating therapeutics. We demonstrated that this recombinant IAV is replication-competent in tissue culture and pathogenic in mice, although it is slightly attenuated compared to the parental virus. Luciferase expression correlated well with virus propagation both in vitro and in vivo, providing a simple measure for viral replication in tissue culture and in mouse lungs. To demonstrate the utility of this virus, ribavirin and oseltamivir phosphate were used to treat the IAV-infected cells and mice, and we observed the dose-dependent inhibition of viral replication by a luciferase assay. Moreover, the decreased luciferase expression in the infected lungs could predict the protective efficacy of antiviral interventions as early as day 2 post virus challenge. In summary, this study provides a new and quantitative approach to evaluate antivirals against IAV.http://www.mdpi.com/1999-4915/10/6/325influenza A virusGaussia luciferaseantiviraltherapeutics
spellingShingle Ping Li
Qinghua Cui
Lin Wang
Xiujuan Zhao
Yingying Zhang
Balaji Manicassamy
Yong Yang
Lijun Rong
Ruikun Du
A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
Viruses
influenza A virus
Gaussia luciferase
antiviral
therapeutics
title A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
title_full A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
title_fullStr A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
title_full_unstemmed A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
title_short A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
title_sort simple and robust approach for evaluation of antivirals using a recombinant influenza virus expressing gaussia luciferase
topic influenza A virus
Gaussia luciferase
antiviral
therapeutics
url http://www.mdpi.com/1999-4915/10/6/325
work_keys_str_mv AT pingli asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT qinghuacui asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT linwang asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT xiujuanzhao asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT yingyingzhang asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT balajimanicassamy asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT yongyang asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT lijunrong asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT ruikundu asimpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT pingli simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT qinghuacui simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT linwang simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT xiujuanzhao simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT yingyingzhang simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT balajimanicassamy simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT yongyang simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT lijunrong simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase
AT ruikundu simpleandrobustapproachforevaluationofantiviralsusingarecombinantinfluenzavirusexpressinggaussialuciferase